thMSC-EVs reduced tissue damage, pulmonary edema, inflammatory cytokine levels (CCL2, TNF-α, and IL-6), and damaged lung regions on CT image analysis, which are crucial therapeutic indicators of ARDS/ALI. This evidence concerns the gene IL6 and acute respiratory distress syndrome.